Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C G Tjan-Heijnen

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 13, 2017
[A plea for selective use of the MammaPrint test]M de Boer, A C Voogd, V C G Tjan-Heijnen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawnV C G Tjan-Heijnen, D J T Wagener, P E Postmus
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patientsN C Verheuvel, A C Voogd, V C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment|September 2, 2017
Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosisN C Verheuvel, A C Voogd, V C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment|February 27, 2003
The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapyP Manders, P Bult, C G J Sweep, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 24, 2007
[Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment]P M M B Soetekouw, R van Dongen, R Maas, et al.
Breast (Edinburgh, Scotland)|April 29, 2016
Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastasesN C Verheuvel, H W A Ooms, V C G Tjan-Heijnen, et al.
International Journal of Oncology|July 16, 2004
Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patientsP Manders, L V A M Beex, V C G Tjan-Heijnen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 28, 2012
Reliability of receptor assessment on core needle biopsy in breast cancer patientsS C Seferina, M Nap, F van den Berkmortel, et al.
Journal of the National Cancer Institute|March 2, 2010
Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastasesM de Boer, J A A M van Dijck, P Bult, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Geneeskunde|April 13, 2017
[A plea for selective use of the MammaPrint test]M de Boer, A C Voogd, V C G Tjan-Heijnen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawnV C G Tjan-Heijnen, D J T Wagener, P E Postmus
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patientsN C Verheuvel, A C Voogd, V C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment|September 2, 2017
Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosisN C Verheuvel, A C Voogd, V C G Tjan-Heijnen, et al.
Breast Cancer Research and Treatment|February 27, 2003
The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapyP Manders, P Bult, C G J Sweep, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 24, 2007
[Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment]P M M B Soetekouw, R van Dongen, R Maas, et al.
Breast (Edinburgh, Scotland)|April 29, 2016
Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastasesN C Verheuvel, H W A Ooms, V C G Tjan-Heijnen, et al.
International Journal of Oncology|July 16, 2004
Vascular endothelial growth factor levels do not predict efficacy of systemic adjuvant treatment as assessed in 1127 breast cancer patientsP Manders, L V A M Beex, V C G Tjan-Heijnen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 28, 2012
Reliability of receptor assessment on core needle biopsy in breast cancer patientsS C Seferina, M Nap, F van den Berkmortel, et al.
Journal of the National Cancer Institute|March 2, 2010
Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastasesM de Boer, J A A M van Dijck, P Bult, et al.
Pageof 8